Green Cross Medical Science Corporation Tangible Net Worth Ratio
Green Cross Medical Science Corporation tangible net worth ratio. Green Cross Medical Science Corporation (142280) has a Tangible Net Worth Ratio of 98.8% as of June 2026. This metric is calculated by deducting intangible assets (₩671.50 Million) from net assets (₩56.08 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check 142280 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Green Cross Medical Science Corporation (2014–2025)
Tangible net worth ratio of Green Cross Medical Science Corporation from 2014 to 2025. This chart shows how Green Cross Medical Science Corporation's Tangible Net Worth Ratio has changed across 12 annual periods from 2014 to 2025. As of June 2026, the ratio stands at 98.8%, reflecting net assets of ₩56.08 Billion with intangible assets of ₩671.50 Million KRW. See working capital to net assets of Green Cross Medical Science Corporation to evaluate short-term liquidity relative to the company's equity base.
Green Cross Medical Science Corporation Tangible Net Worth Ratio by Year (2014–2025)
Green Cross Medical Science Corporation tangible net worth ratio by year from 2014 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Green Cross Medical Science Corporation from 2014 to 2025, covering 12 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see 142280 stock market capitalisation.
| Year | Tangible NW Ratio | Net Assets (KRW) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 99.0% | ₩46.37 Billion | ₩483.93 Million | ₩90.51 Billion | ▼ 0.0 pp |
| 2024 | 99.0% | ₩41.21 Billion | ₩428.07 Million | ₩87.97 Billion | ▲ +0.2 pp |
| 2023 | 98.8% | ₩36.92 Billion | ₩441.80 Million | ₩90.53 Billion | ▼ -0.4 pp |
| 2022 | 99.2% | ₩33.25 Billion | ₩254.64 Million | ₩96.47 Billion | ▼ -0.2 pp |
| 2021 | 99.5% | ₩36.11 Billion | ₩197.92 Million | ₩95.63 Billion | ▼ -0.1 pp |
| 2020 | 99.6% | ₩56.47 Billion | ₩234.29 Million | ₩105.60 Billion | ▲ +0.1 pp |
| 2019 | 99.5% | ₩49.58 Billion | ₩272.10 Million | ₩88.87 Billion | ▲ +4.5 pp |
| 2018 | 95.0% | ₩15.34 Billion | ₩769.14 Million | ₩63.97 Billion | ▼ -1.1 pp |
| 2017 | 96.1% | ₩23.23 Billion | ₩905.31 Million | ₩60.54 Billion | ▲ +6.4 pp |
| 2016 | 89.7% | ₩26.85 Billion | ₩2.76 Billion | ₩63.61 Billion | ▲ +0.7 pp |
| 2015 | 89.1% | ₩28.87 Billion | ₩3.16 Billion | ₩72.61 Billion | ▼ -8.6 pp |
| 2014 | 97.6% | ₩31.50 Billion | ₩746.19 Million | ₩52.10 Billion | — |